The more specific biological functions of sialic acids appear to depend upon diversity generated by different linkages to the underlying sugar chain, and by modifications such as O-acetylation. Alpha-2-6-linked sialic acids are present in B and T-cells, endothelial cells and hepatocytes. This sequence generates ligands for CD22, a B cell-specific member of the new family of """"""""I-type lectins of the immunoglobulin superfamily. These ligands can be masked by O-acetylation of the sialic acids. Alpha-2-8-linked sialicacids on gangliosides can also be selectively O-acetylated in melanoma cells, neuroectodermal tissues, and certain leucocytes. Biosynthesis of these sequences involves specific sialyltransferases and O-acetyltransferase(s) - while some of the former have been purified and cloned, the latter have not. Ablation of 9-O- acetylation by Influenza C hemagglutinin-esterase (CHE) can help to elucidate functions of this modification. A recombinant soluble form of CHE has been developed for this purpose, and can be modified to probe for 9-O-acetylation in cells and tissues. Human melanoma gangliosidesialic acids can also be de-N-acetylated, and the tyrosine kinase inhibitor genistein increases expression of this modification. We now propose to focus upon the following: 1. Compare the tissue distribution of 9-O-acetylation, among four mammalian species.This is made possible by a CHE-based probe. O- acetylation should be conserved in tissues where it is of broad relevance. 2. Cell cycle dependence of 9-O-acetylation and de-N-acetylation of sialic acids. Preliminary studies indicate that these modifications my be regulated in a cell-cycle-dependent manner. 3. Attempts at molecular cloning of the sialic acid-specific O- acetyltransferase(s). All attempts to purify these enzymes have failed - expression cloning will be attempted using multiple approaches. 4.Study the mechanisms of de- and re-N-acetylation of sialic acids in melanoma cells. If time allows, we will pursue the enzymatic mechanisms by which de-N-acetylation occurs with genstein treatment. 5. Study the effect of B-cells activation on CD22, CD22 ligands and O- acetylation. Polyclonally activated B-cells will be studied for changes in the expression and connection of CD22 and its ligands. 6. Compare sialic acid recognition by human CD22beta with that by mouse CD22. This comparative study is critical for the planning of the aim #7. 7. Use sialyloligosaccharides or 9-de-O-acetylation to perturb T-B cell interactions in vitro, and in vivo. The outcome will be studied both in terms of tissue morphology, as well as the immune response. 8. Abrogate CD22 expression in the mo use by gene disruption and/or tissue-specific gene deletion. This will provide critical in formation regarding the role of CD22 lectin in the immune response. 9. Study the structure of CD22 and CHIC in complex with cognate oligosaccharides. Recombinant CD22 and CHE will be used to obtain a crystal structure, and to define the interaction-with sialic acids. 10.Ultrastructurally localize the previously described """"""""cytosolic"""""""" CD22. This pool of CD22 persists almost throughout the life span of a B- lymphocyte. Its location has an important bearing on CD22 function.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37GM032373-17
Application #
6018582
Study Section
Pathobiochemistry Study Section (PBC)
Project Start
1983-08-01
Project End
2000-07-31
Budget Start
1999-08-01
Budget End
2000-07-31
Support Year
17
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Gao, Xiang; Deng, Lingquan; Stack, Gabrielle et al. (2017) Evolution of host adaptation in the Salmonella typhoid toxin. Nat Microbiol 2:1592-1599
Mahajan, Vinay S; Demissie, Ezana; Mattoo, Hamid et al. (2016) Striking Immune Phenotypes in Gene-Targeted Mice Are Driven by a Copy-Number Variant Originating from a Commercially Available C57BL/6 Strain. Cell Rep 15:1901-9
Martin, Paul T; Camboni, Marybeth; Xu, Rui et al. (2013) N-Glycolylneuraminic acid deficiency worsens cardiac and skeletal muscle pathophysiology in ?-sarcoglycan-deficient mice. Glycobiology 23:833-43
Kikkeri, Raghavendra; Padler-Karavani, Vered; Diaz, Sandra et al. (2013) Quantum dot nanometal surface energy transfer based biosensing of sialic acid compositions and linkages in biological samples. Anal Chem 85:3864-70
Scobie, Linda; Padler-Karavani, Vered; Le Bas-Bernardet, Stephanie et al. (2013) Long-term IgG response to porcine Neu5Gc antigens without transmission of PERV in burn patients treated with porcine skin xenografts. J Immunol 191:2907-15
Kavaler, Sarah; Morinaga, Hidetaka; Jih, Alice et al. (2011) Pancreatic beta-cell failure in obese mice with human-like CMP-Neu5Ac hydroxylase deficiency. FASEB J 25:1887-93
Chandrasekharan, Kumaran; Yoon, Jung Hae; Xu, Ying et al. (2010) A human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophy. Sci Transl Med 2:42ra54
Cariappa, Annaiah; Takematsu, Hiromu; Liu, Haoyuan et al. (2009) B cell antigen receptor signal strength and peripheral B cell development are regulated by a 9-O-acetyl sialic acid esterase. J Exp Med 206:125-38
Varki, Ajit; Geschwind, Daniel H; Eichler, Evan E (2008) Explaining human uniqueness: genome interactions with environment, behaviour and culture. Nat Rev Genet 9:749-63
Hedlund, Maria; Ng, Elisa; Varki, Ajit et al. (2008) alpha 2-6-Linked sialic acids on N-glycans modulate carcinoma differentiation in vivo. Cancer Res 68:388-94

Showing the most recent 10 out of 41 publications